135 related articles for article (PubMed ID: 25118716)
21. Safety Profile of PrePex Male Circumcision Device and Client Satisfaction With Adolescent Males Aged 13-17 Years in Zimbabwe.
Tshimanga M; Hatzold K; Mugurungi O; Mangwiro T; Ncube G; Xaba S; Chatikobo P; Gundidza P; Samkange C; Dhlamini R; Murwira M; Gwinji G
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S36-42. PubMed ID: 27331588
[TBL] [Abstract][Full Text] [Related]
22. Mass safe male circumcision: early lessons from a Ugandan urban site - a case study.
Galukande M; Sekavuga DB; Duffy K; Wooding N; Rackara S; Nakaggwa F; Nagaddya T; Elobu AE; Coutinho A
Pan Afr Med J; 2012; 13():88. PubMed ID: 23396906
[TBL] [Abstract][Full Text] [Related]
23. Comparative Cost Analysis of Surgical and PrePex Device Male Circumcision in Zimbabwe and Mozambique.
Schutte C; Tshimanga M; Mugurungi O; Come I; Necochea E; Mahomed M; Xaba S; Bossemeyer D; Ferreira T; Macaringue L; Chatikobo P; Gundididza P; Hatzold K
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S96-S100. PubMed ID: 27331599
[TBL] [Abstract][Full Text] [Related]
24. The PrePex device is unlikely to achieve cost-savings compared to the forceps-guided method in male circumcision programs in sub-Saharan Africa.
Obiero W; Young MR; Bailey RC
PLoS One; 2013; 8(1):e53380. PubMed ID: 23349708
[TBL] [Abstract][Full Text] [Related]
25. Perceptions of the PrePex Device Among Men Who Received or Refused PrePex Circumcision and People Accompanying Them.
Milovanovic M; Taruberekera N; Martinson N; Lebina L
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S78-82. PubMed ID: 27331596
[TBL] [Abstract][Full Text] [Related]
26. What device would be best for early infant male circumcision in east and southern Africa? Provider experiences and opinions with three different devices in Kenya.
Bailey RC; Nyaboke I; Otieno FO
PLoS One; 2017; 12(2):e0171445. PubMed ID: 28196085
[TBL] [Abstract][Full Text] [Related]
27. Unexpected Complications Following Adult Medical Male Circumcision Using the PrePex Device.
Odoyo-June E; Feldblum PJ; Fischer S; Bailey RC; Obiero W; Hart C; Veena V; Combes S; Cherutich P
Urol Int; 2016; 96(2):188-93. PubMed ID: 26684654
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of the PrePex device in HIV-positive men: A single-arm study in Zimbabwe.
Tshimanga M; Makunike-Chikwinya B; Mangwiro T; Tapiwa Gundidza P; Chatikobo P; Murenje V; Herman-Roloff A; Kilmarx PH; Holec M; Gwinji G; Mugurungi O; Murwira M; Xaba S; Barnhart S; Feldacker C
PLoS One; 2017; 12(12):e0189146. PubMed ID: 29220392
[TBL] [Abstract][Full Text] [Related]
29. Timing of adverse events among voluntary medical male circumcision clients: Implications from routine service delivery in Zimbabwe.
Feldacker C; Bochner AF; Murenje V; Makunike-Chikwinya B; Holec M; Xaba S; Balachandra S; Mandisarisa J; Sidile-Chitimbire V; Barnhart S; Tshimanga M
PLoS One; 2018; 13(9):e0203292. PubMed ID: 30192816
[TBL] [Abstract][Full Text] [Related]
30. Safety, Feasibility, and Acceptability of the PrePex Device for Adult Male Circumcision in Malawi.
Kohler PK; Tippett Barr BA; Kangʼombe A; Hofstee C; Kilembe F; Galagan S; Chilongozi D; Namate D; Machaya M; Kabwere K; Mwale M; Msunguma W; Reed J; Chimbwandira F
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S49-55. PubMed ID: 27331590
[TBL] [Abstract][Full Text] [Related]
31. Cost Analysis of Adult Male Circumcision with the PrePex Device versus Surgery in Rwanda.
Mutabazi V; Bitega JP; Muyenzi Ngeruka L; Nyemazi JP; Dain M; Kaplan SA; Karema C; Binagwaho A
Urol Nurs; 2014; 34(6):303-11. PubMed ID: 26298926
[TBL] [Abstract][Full Text] [Related]
32. Evaluating Opportunities for Achieving Cost Efficiencies Through the Introduction of PrePex Device Male Circumcision in Adult VMMC Programs in Zambia and Zimbabwe.
Vandament L; Chintu N; Yano N; Mugurungi O; Tambatamba B; Ncube G; Xaba S; Mpasela F; Muguza E; Mangono T; Madidi N; Samona A; Tagar E; Hatzold K
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S90-5. PubMed ID: 27331598
[TBL] [Abstract][Full Text] [Related]
33. Can devices for adult male circumcision help bridge the implementation gap for HIV prevention services?
McIntyre JA
J Acquir Immune Defic Syndr; 2011 Dec; 58(5):506-8. PubMed ID: 21963938
[TBL] [Abstract][Full Text] [Related]
34. Long term post PrePex male circumcision outcomes in an urban population in Uganda: a cohort study.
Galukande M; Nakaggwa F; Busisa E; Sekavuga Bbaale D; Nagaddya T; Coutinho A
BMC Res Notes; 2017 Oct; 10(1):522. PubMed ID: 29084559
[TBL] [Abstract][Full Text] [Related]
35. Genital Anaerobic Bacterial Overgrowth and the PrePex Male Circumcision Device, Rakai, Uganda.
Liu CM; Prodger JL; Tobian AA; Serwadda D; Galiwango RM; Nalugoda F; Kighoma N; Mwinike J; Anyokorit M; Price LB; Wawer MJ; Kigozi G; Gray RH
J Infect Dis; 2016 Aug; 214(4):595-8. PubMed ID: 27190185
[TBL] [Abstract][Full Text] [Related]
36. Non-surgical adult male circumcision using the PrePex device: task-shifting from physicians to nurses.
Mutabazi V; Bitega JP; Ngeruka LM; Hategekimana T; Kaplan SA; Karema C; Binagwaho A
Afr J Reprod Health; 2014 Mar; 18(1):61-70. PubMed ID: 24796170
[TBL] [Abstract][Full Text] [Related]
37. Male circumcision: towards a World Health Organisation normative practice in resource limited settings.
Hargreave T
Asian J Androl; 2010 Sep; 12(5):628-38. PubMed ID: 20639909
[TBL] [Abstract][Full Text] [Related]
38. Exploring drivers for safe male circumcision: Experiences with health education and understanding of partial HIV protection among newly circumcised men in Wakiso, Uganda.
Kibira SP; Daniel M; Atuyambe LM; Makumbi FE; Sandøy IF
PLoS One; 2017; 12(3):e0175228. PubMed ID: 28362880
[TBL] [Abstract][Full Text] [Related]
39. Male circumcision for HIV prevention: a prospective study of complications in clinical and traditional settings in Bungoma, Kenya.
Bailey RC; Egesah O; Rosenberg S
Bull World Health Organ; 2008 Sep; 86(9):669-77. PubMed ID: 18797642
[TBL] [Abstract][Full Text] [Related]
40. Field study of adult male circumcision using the ShangRing in routine clinical settings in Kenya and Zambia.
Sokal DC; Li PS; Zulu R; Awori QD; Agot K; Simba RO; Combes S; Lee RK; Hart C; Lai JJ; Zyambo Z; Goldstein M; Feldblum PJ; Barone MA
J Acquir Immune Defic Syndr; 2014 Dec; 67(4):430-7. PubMed ID: 25162816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
